Filing metadata

Accession number
0001209191-22-037424
Form type
Form 4
Filer
Janux Therapeutics, Inc.
CIK
CIK 1817713
Filed
Jun 16, 2022
Reporting period
Jun 14, 2022
Description
Insider transaction

Explore SEC Filings Hub